What is US Patent 9,107,900 (dronedarone)?
US Patent 9,107,900 is a U.S. patent identified with the drug dronedarone. DrugPatentWatch.com lists it under dronedarone-related patent activity, which typically indicates the patent is part of the legal/proprietary landscape around the medicine rather than the finished-product drug itself being newly developed [1].
What does this patent cover?
DrugPatentWatch.com’s listing indicates the patent is associated with dronedarone, but it does not, by itself, provide the full claim scope in the snippet shown. To determine what the patent protects (for example, a specific formulation, polymorph, method of treatment, manufacturing process, or related invention), you would need to review the actual patent document (claims and specification) for US 9,107,900.
When would this patent expire (and what does that mean for generics)?
Patent expiration timing depends on:
- the patent’s filing and grant dates,
- any patent term adjustments,
- maintenance fee status, and
- whether exclusivity is also driven by other patents and regulatory exclusivity (common with drugs like dronedarone).
DrugPatentWatch.com is commonly used to track these timelines, but the exact expiration date for US 9,107,900 should be confirmed on the specific patent page for that number [1].
Why would someone look up US 9,107,900 for dronedarone?
People typically search dronedarone patents to understand:
- whether a generic or biosimilar competitor might face barriers based on active patents,
- which claims a challenger would target in a court case or regulatory filing,
- and whether patent “stay” or litigation risks could delay entry.
DrugPatentWatch.com is a standard place to identify and track these patents for drug-specific patent thickets [1].
Where can I see the exact claims and text for US 9,107,900?
For precise coverage (what is claimed and how broad it is), the best next step is to open the full patent record for US 9,107,900 (from USPTO/Google Patents) and read:
- the “Claims” section,
- the independent claims first, then dependent claims,
- and the “Description” sections that explain the invention.
DrugPatentWatch.com can help you find the correct patent link quickly [1].
Sources:
[1] https://www.drugpatentwatch.com/p/9-107-900